L
9.06
0.15 (1.68%)
| Penutupan Terdahulu | 8.91 |
| Buka | 8.85 |
| Jumlah Dagangan | 666,791 |
| Purata Dagangan (3B) | 1,148,870 |
| Modal Pasaran | 661,265,216 |
| Harga / Buku (P/B) | 5.82 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| EPS Cair (TTM) | -3.31 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.67% |
| Nisbah Semasa (MRQ) | 3.41 |
| Aliran Tunai Operasi (OCF TTM) | -88.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -50.43 M |
| Pulangan Atas Aset (ROA TTM) | -42.89% |
| Pulangan Atas Ekuiti (ROE TTM) | -80.65% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Lexeo Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
0.9
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.88 |
|
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.75% |
| % Dimiliki oleh Institusi | 121.45% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 30.00 (Guggenheim, 231.13%) | Beli |
| Median | 19.00 (109.71%) | |
| Rendah | 13.00 (HC Wainwright & Co., 43.49%) | Beli |
| Purata | 19.80 (118.54%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 8.78 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Cantor Fitzgerald | 01 Dec 2025 | 19.00 (109.71%) | Beli | 8.92 |
| 20 Nov 2025 | 19.00 (109.71%) | Beli | 8.91 | |
| Chardan Capital | 05 Nov 2025 | 17.00 (87.64%) | Beli | 8.20 |
| 07 Oct 2025 | 17.00 (87.64%) | Beli | 8.34 | |
| HC Wainwright & Co. | 21 Oct 2025 | 13.00 (43.49%) | Beli | 9.60 |
| 07 Oct 2025 | 15.00 (65.56%) | Beli | 8.34 | |
| Guggenheim | 15 Oct 2025 | 30.00 (231.13%) | Beli | 8.83 |
| Leerink Partners | 07 Oct 2025 | 20.00 (120.75%) | Beli | 8.34 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |